Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Libutti

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Cancer Gene Therapy|February 5, 2014
New horizons for cancer gene therapyS K Libutti
Cancer Gene Therapy|December 15, 2015
Navigating the regulatory road to approval for cancer gene therapiesS K Libutti
Cancer Gene Therapy|March 11, 2015
Genetically engineered lymphocytes and adoptive cell therapy: cancer immunotherapy's smart bombsS K Libutti
Cancer Research|March 23, 2000
Correspondence re: Q-R. Chen et al., Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res., 59: 3308-3312, 1999A L Feldman, S K Libutti
Expert Opinion on Biological Therapy|December 1, 2001
General aspects of anti-angiogenesis and cancer therapyT G Zogakis, S K Libutti
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Tumor angiogenesis and endothelial cell modulatory factorsS B Desai, S K Libutti
Surgical Endoscopy|September 1, 1994
Laparoscopic resection of a nonparasitic liver cystS K Libutti, P M Starker
Cancer|September 26, 2000
Progress in antiangiogenic gene therapy of cancerA L Feldman, S K Libutti
Current Opinion in Investigational Drugs (London, England : 2000)|August 31, 2001
Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculatureM L Kayton, S K Libutti
Oral Diseases|November 11, 2008
The tumour microenvironment: a novel target for cancer therapyE Hanna, J Quick, S K Libutti
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Cancer Gene Therapy|February 5, 2014
New horizons for cancer gene therapyS K Libutti
Cancer Gene Therapy|December 15, 2015
Navigating the regulatory road to approval for cancer gene therapiesS K Libutti
Cancer Gene Therapy|March 11, 2015
Genetically engineered lymphocytes and adoptive cell therapy: cancer immunotherapy's smart bombsS K Libutti
Cancer Research|March 23, 2000
Correspondence re: Q-R. Chen et al., Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res., 59: 3308-3312, 1999A L Feldman, S K Libutti
Expert Opinion on Biological Therapy|December 1, 2001
General aspects of anti-angiogenesis and cancer therapyT G Zogakis, S K Libutti
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Tumor angiogenesis and endothelial cell modulatory factorsS B Desai, S K Libutti
Surgical Endoscopy|September 1, 1994
Laparoscopic resection of a nonparasitic liver cystS K Libutti, P M Starker
Cancer|September 26, 2000
Progress in antiangiogenic gene therapy of cancerA L Feldman, S K Libutti
Current Opinion in Investigational Drugs (London, England : 2000)|August 31, 2001
Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculatureM L Kayton, S K Libutti
Oral Diseases|November 11, 2008
The tumour microenvironment: a novel target for cancer therapyE Hanna, J Quick, S K Libutti
Pageof 10